Catheter ABlation vs ANtiarrhythmic Drug Therapy in Atrial Fibrillation CABANA trial

Published On 2021-12-07T17:33:18+05:30 | Updated On 15 Dec 2021 6:25 AM GMT

Overview

Radiofrequency ablation for atrial fibrillation (AF) is an "economically attractive" option compared with drug therapy, according to a new cost-effectiveness analysis of the CABANA trial. CABANA missed its primary endpoint—radiofrequency ablation did not significantly reduce all-cause mortality, disabling stroke, serious bleeding, or cardiac arrest when compared with drug therapy in 2,204 patients with new-onset or undertreated AF.

However, there were significant improvements in quality of life, freedom from AF recurrence, and AF burden.

Economic considerations for catheter ablation to improve quality of life or reduce symptom burden are important in this era of escalating healthcare costs and value-based care.

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Dr. Prem Aggarwal

MBBS,MD, DNB (Cardiology)

Dr Prem Aggarwal, (DNB Cardiology) is an Cardiologist by profession and also the Co-founder of Medical Dialogues. An avid researcher, he is currently associated with GB Pant Hospital (GIPMER) New Delhi as a PhD Fellow pursuing his research on the topic of Angioplasties on Surgical Rejects